nimustine has been researched along with Dysgerminoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Himuro, H; Inoue, N; Kaetsu, I; Kitamura, K; Kubo, O; Sakairi, M; Tajika, T; Tajika, Y; Tohyama, T; Yoshida, M | 1 |
| Kawakami, K; Kawamoto, K; Kawamura, Y; Matsumura, H; Miki, K; Nishimura, T; Oka, N; Okuyama, T; Ouchi, M | 1 |
2 other study(ies) available for nimustine and Dysgerminoma
| Article | Year |
|---|---|
[Treatment of malignant brain tumors with slowly releasing anticancer drug-polymer composites].
Topics: Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Implants; Dysgerminoma; Ependymoma; Fluorouracil; Glioma; Humans; Medulloblastoma; Methylmethacrylates; Mitomycin; Mitomycins; Neoplasms, Germ Cell and Embryonal; Nimustine; Nitrosourea Compounds; Teratoma | 1986 |
[Clinico-immunological evaluation of T cells bearing IgG Fc receptors in brain tumor patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dysgerminoma; Humans; Immunoglobulin A; Immunoglobulin Fc Fragments; Immunoglobulin Fragments; Immunoglobulin M; Lymphocyte Activation; Nimustine; Nitrosourea Compounds; Phytohemagglutinins; Picibanil; Receptors, IgG; Receptors, Immunologic; T-Lymphocytes | 1985 |